홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Toluene → 1-{4-[9-[(1R,2S,3R,4S)-2,3-Dihydroxy-4-(4-methyl-pyrazol-1-yl)-cyclopentyl]-6-(2,2-diphenyl-ethylamino)-9H-purin-2-ylamino]-cyclohexyl}-3-(3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-urea Trifluoroacetate

HRID 1641910
노트
인쇄 미리보기

반응식

HRID 1641910 반응식
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[NH2:8][CH:9]1[CH2:14][CH2:13][CH:12]([NH:15][C:16]2[N:24]=[C:23]3[C:19]([N:20]=[CH:21][N:22]3[C@@H:25]3[CH2:29][C@H:28]([N:30]4[CH:34]=[C:33]([CH3:35])[CH:32]=[N:31]4)[C@@H:27]([OH:36])[C@H:26]3[OH:37])=[C:18]([NH:38][CH2:39][CH:40]([C:47]3[CH:52]=[CH:51][CH:50]=[CH:49][CH:48]=3)[C:41]3[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=3)[N:17]=2)[CH2:11][CH2:10]1.C1(C)C=CC=CC=1.CC(O)C.[N:64]1[CH:69]=[CH:68][CH:67]=[CH:66][C:65]=1[N:70]1[CH2:75][CH2:74][CH:73]([NH:76][C:77](N2C=CN=C2)=[O:78])[CH2:72][CH2:71]1>C(Cl)Cl>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[OH:37][C@@H:26]1[C@H:27]([OH:36])[C@@H:28]([N:30]2[CH:34]=[C:33]([CH3:35])[CH:32]=[N:31]2)[CH2:29][C@H:25]1[N:22]1[CH:21]=[N:20][C:19]2[C:23]1=[N:24][C:16]([NH:15][CH:12]1[CH2:11][CH2:10][CH:9]([NH:8][C:77]([NH:76][CH:73]3[CH2:72][CH2:71][N:70]([C:65]4[CH:66]=[CH:67][CH:68]=[CH:69][N:64]=4)[CH2:75][CH2:74]3)=[O:78])[CH2:14][CH2:13]1)=[N:17][C:18]=2[NH:38][CH2:39][CH:40]([C:41]1[CH:46]=[CH:45][CH:44]=[CH:43][CH:42]=1)[C:47]1[CH:48]=[CH:49][CH:50]=[CH:51][CH:52]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 1140TolueneHCID 3776IsopropanolHCID 21978278N-[1-(2-pyridinyl)-4-piperidinyl]-1H-imidazole-1-carboxamideHCID 66736662(1R,2S,3R,5S)-3-[2-(4-Amino-cyclohexylamino)-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(4-methyl-pyrazol-1-yl)-cyclopentane-1,2-diol trifluoroacetate

생성물 1

HCID 86622811
1-{4-[9-[(1R,2S,3R,4S)-2,3-Dihydroxy-4-(4-methyl-pyrazol-1-yl)-cyclopentyl]-6-(2,2-diphenyl-ethylamino)-9H-purin-2-ylamino]-cyclohexyl}-3-(3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-urea Trifluoroacetate

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

(1R,2S,3R,5S)-3-[2-(4-Amino-cyclohexylamino)-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(4-methyl-pyrazol-1-yl)-cyclopentane-1,2-diol trifluoroacetate (Example 1) (0.020 g, 0.028 mmol) is dissolved in DCM (2 ml). Toluene (2 ml) and iPrOH (1 ml) are added followed by N-[1-(2-pyridinyl)-4-piperidinyl]-1H-imidazole-1-carboxamide (which is prepared using the method described in international patent application WO 01/94368) (0.03 mmol of a 0.1 M solution in DCM). The dichloromethane is removed by vacuo and the reaction mixture is stirred at room temperature. The reaction is shown to be complete by LCMS after 48 hours. The solvent is removed in vacuo. The title compound is obtained by flash column chromatography (Isolute™ C18, 0-100% acetonitrile in water—0.1% TFA). MS (ES+) m/e 811.5 (MH+).

후처리

  1. customis prepared
  2. customThe dichloromethane is removed by vacuo
  3. customThe solvent is removed in vacuo

출처 및 근거

ORD 기록
ord-89af76e7d5ae4f7385c2196785b2b6e4
출처 데이터셋
uspto-grants-2012_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08114877B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트